Continuous-flow precipitation of hydroxyapatite at 37 °C in a meso oscillatory flow reactor by Castro, Filipa et al.
Continuous-Flow Precipitation of Hydroxyapatite at 37 °C in a Meso
Oscillatory Flow Reactor
Filipa Castro,*,† Antońio Ferreira,†,‡ Fernando Rocha,‡ Antońio Vicente,† and Jose ́ Antońio Teixeira†
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ABSTRACT: Continuous-ﬂow precipitation of hydroxyapatite (HAp) was investigated in a meso oscillatory ﬂow reactor (meso-
OFR) and in a scaled-up meso-OFR, obtained by associating in series eight vertical meso-ORFs. Experiments were carried out
under near-physiological conditions of temperature and pH, using ﬁxed frequency ( f = 0.83 Hz) and amplitude (x0 = 4.5 mm),
and varying the residence time from 0.4 to 6.7 min. It has been shown that the mean particle size and the aggregation degree of
the prepared HAp particles decrease with decreasing residence time. HAp nanoparticles with a mean size (d50) of 77 nm, narrow
size distribution, and uniform morphology were obtained at the lowest residence times, τ = 0.4 and 3.3 min in the meso-OFR and
the scaled-up meso-OFR, respectively. These results show the capability of the meso-OFR and the scaled-up meso-OFR for
continuous production of uniform HAp nanoparticles, while also conﬁrming the possibility of OFR scale-up by in series
association of individual OFRs.
1. INTRODUCTION
Hydroxyapatite (HAp), Ca5(PO4)3OH, has been extensively
used in bone replacement applications due to its biocompat-
ibility, bioactivity, and osteoconductivity.1 In this context, it is
desirable that HAp crystals meet speciﬁc requirements, such as
high speciﬁc surface area (favored by small crystal size), narrow
size distribution, and high purity, in order to optimize bone-
related cell growth around them.1,2
Traditional stirred tank batch reactors for synthetic
production of HAp provide only limited amounts of material,
and crystallization conditions may change during multiple
syntheses.3 In this kind of system, low mixing eﬃciency and
wide residence time distributions lead to a heterogeneous
distribution of supersaturation in the reaction medium, thus
aﬀecting the crystal size distribution and chemical purity of the
precipitated particles. The problem is magniﬁed as the scale of
operation increases, since the control of mixing is very diﬃcult
in large vessels,4 and can be particularly pronounced in fast
precipitation systems owing to the very fast reaction
kinetics.5This can lead to problems in achieving consistent
product speciﬁcations.3 Even small diﬀerences in stoichiometry,
morphology, or size may aﬀect the chemical, biological, and
physical behaviors of the material.6 On one hand, scale-up is
necessary to increase production rate, and on the other hand
the science of reactive precipitation makes it diﬃcult to apply
precipitations to industrial scale batch operations under well-
deﬁned and reproducible conditions.
Continuous operation oﬀers signiﬁcant advantages in terms
of process and costs.3,7,8 It allows more eﬃcient use of reagents,
solvents, energy, and space while minimizing the production of
waste materials and reactor downtime for reactor maintenance
and cleaning. Further, it aﬀords the advantage of enhanced
reproducibility of results because all material crystallizes under
uniform conditions, resulting in the formation of crystals with
consistent properties.3 In addition, continuous operations allow
higher productivity and permit the continuous variation of the
chemical composition of the reaction medium.
The application of periodic ﬂuid oscillations to a cylindrical
column containing evenly spaced oriﬁce baﬄes is the basic
concept of an oscillatory ﬂow reactor (OFR).9 The OFR can be
operated batchwise or continuously in horizontal or vertical
tubes. The ﬂuid is typically oscillated in the axial direction by
means of diaphragms, bellows, or pistons, at one or both ends
of the tube, developing an eﬃcient mixing mechanism
(oscillatory ﬂow mixing) where ﬂuid moves from the walls to
the center of the tube with intensity controlled by the
oscillation frequency and amplitude.9−11 In recent years, the
study of oscillatory ﬂow mixing within OFRs has increasingly
been applied to various industrial processes, such as suspension
polymerization, crystallization, paint dispersion, ﬂocculation,
and fermentation.12−17
In this work, a simple apparatus for the continuous
preparation of HAp nanoparticles under near-physiological
conditions of temperature and pH is presented. Continuous-
ﬂow precipitation of HAp was performed in a meso oscillatory
ﬂow reactor (meso-OFR) and in the scaled-up meso-OFR,
which were suitable for continuous high throughput screening
due to their small volumes (milliliters). HAp precipitation was
carried out at 37 °C, for a mixing molar ratio Ca/P of 1.33, and
at diﬀerent residence times τ = 0.9 and 0.4 min for the meso-
OFR and τ = 6.7 and 3.3 min for the scaled-up meso-OFR.
Characteristics of the prepared powders (purity, size, size
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distribution, and morphology) were evaluated for all the
operating conditions.
2. MATERIALS AND METHODS
2.1. Description of the Experimental Setup. The meso-
OFR consists of a 35 cm long and 4.4 mm internal diameter
glass jacketed tube provided with smooth periodic cavities
(SPC), with an average baﬄe spacing of 13 mm and a baﬄe
thickness of 6 mm.9,18,19 The diameter of the constricted zone
(baﬄe internal diameter) is 1.6 mm, leading to a baﬄe free area
of 13%.9 The reactor has an approximate volume of 4 mL.
HAp precipitation was ﬁrst carried out in the meso-OFR
operated continuously in a vertical tube (see Figure 1).
HAp precipitation was then carried out in the scaled-up
meso-OFR. For this, eight meso-OFRs were positioned in
series, with each meso-OFR placed vertically (see Figure 2).
For both experimental apparatuses, the ﬂuid was oscillated
using a piston moved by a stirring motor (CAT R100C). The
oscillating system was custom-built. Based on preliminary
experiments, the oscillation amplitude (x0) and frequency ( f)
were ﬁxed at 4.5 mm and 0.83 Hz, respectively. The value of
the amplitude corresponds to the center-to-peak amplitude, and
the measurements were performed in the tube without
constrictions. Reactants were fed into the setups by means of
a peristaltic pump (ISMATEC IPS 8, Switzerland). The
temperature of the reactants and the temperature inside the
meso-OFRs were regulated by a thermostatic bath maintained
at 37 °C.
2.2. Powder Preparation. HAp was synthesized by the
mixing of a saturated calcium hydroxide (Sigma-Aldrich, 95%)
aqueous solution and an orthophosphoric acid (Mallinckrodt,
85%) aqueous solution at 37 °C, with a mixing molar ratio Ca/
P = 1.33. This mixing molar ratio was deﬁned in order to obtain
the desired product, e.g., HAp, under conditions that promote
the survival of bone-related cells, e.g., physiological conditions
of pH and temperature. After several preliminary experiments,
the mixing molar ratio Ca/P = 1.33 was conﬁrmed as the one
that allowed obtaining the desired product at near-physiological
conditions of pH and temperature. A 0.5 L volume of both
reactants was prepared with ultrapure water (Milli Q water,
resistivity of 18.2 MΩ/cm at 25 °C), and their ionic force was
adjusted by the addition of 6 mL of 4 mol·L−1 potassium
chloride (Mallinckrodt, 99.8%) solution. To facilitate the
dissolution of calcium hydroxide, the solution was agitated in
a closed vessel for 24 h at 500 rpm and at 25 °C, as its solubility
decreases with temperature increase.20 Then, both reactants
were heated and kept at 37 °C.
According to preliminary experiments, f = 0.83 Hz and x0 =
4.5 mm were found to be the best conditions for promoting a
fast mixing and a more homogeneous reaction medium, being
thus deﬁned as the operating conditions. Further, HAp
precipitation was carried out at diﬀerent residence times in
both the meso-OFR and the scaled-up meso-OFR. The
operating conditions are presented in Table 1.
Temperature (inoLab, WTW) and pH (SenTix Mic-D,
WTW) were measured at diﬀerent time intervals at the outlet
of the meso reactor. The pH electrode was calibrated with two
buﬀer solutions at pH 7.00 and 10.00 at 25 °C.
Samples were collected after approximately two to three
residence times, until pH stabilization was achieved.
2.3. Powder Characterization. Samples were withdrawn
at the outlet of the meso reactor, centrifuged (at 1500 rpm for 5
min), washed twice with ultrapure water, and conserved in pure
ethanol (99.8%), which stops the solid−liquid reaction.21 The
Figure 1. Experimental apparatus for the continuous-ﬂow precipitation
of HAp.
Figure 2. Experimental apparatus for the scale-up of the continuous-
ﬂow precipitation of HAp.
Table 1. Operating Conditions for the Continuous-Flow
Precipitation of HAp in the Meso-OFR and in the Scaled-Up
Meso-OFR
reactor
liquid ﬂow rate
(mL/min)
number of
meso-OFRs
total vol
(mL)
τ
(min)
meso-OFR 4.5 1 ≈4 0.9
9.0 1 ≈4 0.4
scaled-up
meso-OFR
4.5 8 ≈30 6.7
9.0 8 ≈30 3.3
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powders obtained were then characterized by X-ray diﬀraction
(XRD; PanAlytical X’Pert PRO Alfa-1 diﬀractometer with λ Cu
Kα = 1.540 56 Å), Fourier transform infrared spectroscopy
(FTIR; Bomem MB-154S), and scanning electron microscopy
(SEM; FEI Quanta 400FEG ESEM/EDAX Genesis X4M with
an accelerating voltage of 15 kV and 20 kV), where samples
were covered by a 10 nm layer of gold. For particle size
distribution, suspensions were collected at the end of each
experiment and directly analyzed by laser diﬀraction (LS 230,
Beckman Coulter). The ﬁnal precipitate was also dried and
weighed for the estimation of the mass of the crystals obtained.
3. RESULTS AND DISCUSSION
3.1. Important Parameters in the Precipitation of
HAp. pH is an important parameter in determining the
likelihood of the formation of calcium phosphate phases.22 The
inﬂuence of pH on the formation of calcium phosphates is
linked to the properties of phosphate-containing solutions. Due
to the triprotic equilibrium in these systems, variations in pH
alter the relative concentrations of the four protonated forms of
phosphoric acid and thus both the chemical composition and
the amount of the CaP formed by direct precipitation.23
In the present work, experiments were conducted under
near-physiological conditions of temperature and pH (Table 2),
which is particularly important when preparing HAp for
medical purposes.
As already mentioned, it is important to follow speciﬁc
criteria for pH and temperature in order to promote more
conductive conditions for the survival of bone-related cells.2
Furthermore, from a thermodynamic point of view, these
conditions favor the precipitation of HAp, since at 37 °C and
pH between 4 and 12, HAp is the most stable calcium
phosphate salt.24 Concerning the quantity of the precipitate
obtained, results presented in Table 2 show that the mass of
precipitate prepared per milliliter is similar for all operating
conditions.
3.2. Continuous-Flow HAp Precipitation. 3.2.1. Phase
Identiﬁcation. The XRD analysis of the prepared powders (see
Figure 3) revealed no secondary phases besides the apatitic
phase, for all the operating conditions studied. XRD patterns of
the diﬀerent powders obtained match well the XRD pattern of a
reference HAp (JCPDS 9-0432) and a commercial HAp
(Spectrum, minimum 40 meshes). However, broadening and
overlap of the peaks are observed, being more pronounced in
the diﬀraction pattern of the particles produced in the scaled-up
meso-OFR. This may imply small crystallites and low
crystallinity, which is similar to natural bone.25 Peaks assigned
to KCl (namely at 28° 2θ and 40.5° 2θ) are also exhibited,
especially in the diﬀraction patterns of the particles prepared in
the scaled-up meso-OFR. This may be explained by the
occlusion of KCl present in the mother liquor, which could
have been trapped in the aggregates and crystallized at the
drying step. KCl peaks are less detected for the lowest residence
times.
It can also be seen that there is a slight shift between the
XRD patterns of the prepared powders and the XRD pattern of
the reference HAp. This is probably due to the experimental
conditions under which XRD analysis was performed, since a
slight shift is also visible in the diﬀraction pattern of the
commercial HAp.
According to Figure 4, FTIR spectra exhibit stretching and
bending vibrations of the phosphate, PO4
3−, and the hydroxyl,
OH−, functional groups, characteristic of a typical apatite
structure.26 However, it is diﬃcult to detect the peak related to
the υ4 bending mode of PO4
3−, and the peaks assigned to the
vibrational mode (around 630 cm−1) and stretching mode
(around 3571 cm−1) of OH− are not well resolved. Concerning
the peak assigned to the stretching mode of OH−, this can be
due to the overlap with the broad band (from approximately
3700 to 3000 cm−1) of the adsorbed water on HAp particles.27
A second peak assigned to adsorbed water is also observed at
Figure 3. XRD patterns of the particles produced in the meso-OFR
and scaled-up meso-OFR operated continuously at diﬀerent operating
conditions.
Table 2. Parameters Measured during Continuous-Flow
Precipitation of HAp in the Meso-OFR and in the Scaled-Up
Meso-OFR, for Diﬀerent Operating Conditions
reactor τ (min) pH precipitate (mg/mL)
meso-OFR 0.9 6.90 0.87
0.4 7.10 0.93
scaled-up meso-OFR 6.7 6.63 0.80
3.3 6.65 0.83
Figure 4. FTIR spectra of the particles produced in the meso-OFR
and scaled-up meso-OFR operated continuously at diﬀerent operating
conditions.
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1643 cm−1 (bending mode, υ2). The presence of adsorbed
water on the HAp prepared particles can be explained by the
low drying temperature (60 °C) and the absence of a ripening
(aging) treatment.18,19,28 In addition, the presence of a peak
(around 875 cm−1) assigned to the vibrational frequencies of
carbonate (CO3
2−) or hydrogen phosphate (HPO4
2−) ions17,20
suggests the formation of a carbonated HAp or calcium-
deﬁcient HAp.
3.2.2. Particle Size, Size Distribution, and Morphology.
According to Figures 5 and 6 (obtained from the conversion of
the particle size distribution in volume) and Tables 3 and 4
(obtained from the conversion of the particle size distribution
in volume), the as-prepared powders consist of a population of
primary particles in the nanometer range and a population of
micrometer-sized aggregates that, given the considerable
diﬀerence in size, could be separated. Aggregates probably
result from the aggregation of primary nanoparticles, since
small particles possess a high surface-area-to-volume ratio,
resulting in a high surface tension which they tend to lower by
adhering to one another.29 Further, the peak observed at 1000
μm (see Figure 5) is probably due to the presence of air
bubbles in the suspensions analyzed. Results also show that the
mean size and the aggregation degree of the as-prepared
particles increase with increasing residence time. On the basis
of Figure 6 and Table 4, HAp particles with a mean size (d50) of
77 nm were obtained at the residence times τ = 0.4 and 3.3
min, for the meso-OFR and the scaled-up meso-OFR,
respectively. Indeed, for higher liquid ﬂow rates, Reynolds
numbers are higher and mixing eﬃciency is enhanced. This
results in a more homogeneous reaction medium and therefore
in a more homogeneous distribution of supersaturation, thus
aﬀecting the size distribution of the particles.30−33 When
compared with the commercial HAp particles (Spectrum,
minimum 40 meshes) originally submitted to granulometric
separation, the HAp particles prepared at the lowest residence
times (τ = 0.4 min for the meso-OFR and τ = 3.3 min for the
scaled-up meso-OFR) have a lower mean size (d50) and a
narrower size distribution (Table 4). However, it is very
important to underline that the particles produced were directly
obtained from the system without thermal treatment and
without granulometric separation.
Figure 7 shows two types of particles for the residence times
τ = 0.9 and 6.7 min, for the meso-OFR and the scaled-up meso-
OFR, respectively: rod-shaped and plate-shaped. Regarding
particles produced at τ = 0.4 and 3.3 min, for the meso-OFR
and the scaled-up meso-OFR, respectively, the morphology
seems more uniform and particles look to be mostly rod-
shaped. In both cases, rod-shaped particles present a size
around 100 nm long and 20 nm wide. As already mentioned,
mixing is more eﬃcient for higher Reynolds numbers,
providing more homogeneous reaction conditions,30,32,33 and
improving thus the monodispersity of synthesized nano-
particles.34−37
Based on the above-mentioned results, the feasibility of the
meso-OFR and the scaled-up meso-OFR was demonstrated for
the continuous production of uniform HAp nanoparticles. In
both the meso-OFR and the scaled-up meso-OFR operated
continuously, single-phase HAp nanoparticles with a mean size
(d50) of 77 nm and a narrow size distribution were obtained.
4. CONCLUSION
Continuous-ﬂow precipitation of HAp was investigated in a
meso-OFR and in a scaled-up meso-OFR. Calcium-deﬁcient
and/or carbonated HAp nanoparticles were successfully
produced in both reactors. The inﬂuence of the residence
time on HAp particle size and size distribution was also studied.
For both reactors, it was found that the mean particle size and
the aggregation degree of the particles decrease with the
decrease of the residence time. In addition, HAp particles more
uniform in size were precipitated for both the meso-OFR and
the scaled-up meso-OFR at the lowest residence times. Single-
phase HAp nanoparticles with a mean size (d50) of 77 nm and a
narrow size distribution were obtained in both the meso-OFR
and the scaled-up meso-OFR. Furthermore, the precipitated
HAp particles show improved quality, namely in terms of size
and size distribution, when compared with a commercial HAp
powder. It is important to note that, unlike the commercial
powder that was previously subjected to granulometric
separation, samples obtained in this study were not submitted
to further treatment. Thus, the proposed scaled-up meso-OFR
may be useful as a high throughput screening tool, namely for
performing reactions which require longer reaction times.
Figure 5. Particle size distribution in volume of particles produced in
the meso-OFR and scaled-up meso-OFR operated continuously at
diﬀerent operating conditions.
Figure 6. Particle size distribution in number of particles produced in
the meso-OFR and scaled-up meso-OFR operated continuously at
diﬀerent operating conditions.
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In summary, the present study demonstrates the capabilities
of a meso-OFR and a scaled-up meso-OFR for the continuous
production of HAp nanoparticles, taking advantage of both
oscillatory ﬂow mixing and continuous operation.
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